Other
Derivatives, gross, liabilities
Merck & Co. Derivatives, gross, liabilities decreased by 29.3% to $229.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.6%, from $268.00M to $229.00M. Over 3 years (FY 2022 to FY 2025), Derivatives, gross, liabilities shows a downward trend with a -7.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2022
Last reportedQ1 2026May 4, 2026
How to read this metric
An increase in liability fair value may indicate adverse market movements or increased hedging costs, potentially impacting liquidity.
Detailed definition
The current market value of derivative financial instruments that are in a liability position. This represents the amoun...
Peer comparison
Standard for large financial services firms; peers vary based on hedging effectiveness.
Metric ID:
other_derivative_fair_value_of_derivative_liabilityHistorical Data
12 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $409.00M | $176.00M | $239.00M | $167.00M | $142.00M | $298.00M | $345.00M | $268.00M | $855.00M | $492.00M | $324.00M | $229.00M |
| QoQ Change | — | -57.0% | +35.8% | -30.1% | -15.0% | +109.9% | +15.8% | -22.3% | +219.0% | -42.5% | -34.1% | -29.3% |
| YoY Change | — | — | -41.6% | — | — | +69.3% | +44.4% | +60.5% | +502.1% | +65.1% | -6.1% | -14.6% |
Range$142.00M – $855.00M
CAGR-19.0%
Avg YoY Growth+84.9%
Median YoY Growth+52.4%
Current Streak3 quarters decline
Derivatives, gross, liabilities at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s derivatives, gross, liabilities?
- Merck & Co. (MRK) reported derivatives, gross, liabilities of $229.00M in Q1 2026.
- How has Merck & Co.'s derivatives, gross, liabilities changed year-over-year?
- Merck & Co.'s derivatives, gross, liabilities decreased by 14.6% year-over-year, from $268.00M to $229.00M.
- What is the long-term trend for Merck & Co.'s derivatives, gross, liabilities?
- Over 3 years (2022 to 2025), Merck & Co.'s derivatives, gross, liabilities has grown at a -7.5% compound annual growth rate (CAGR), from $409.00M to $324.00M.
- What does derivatives, gross, liabilities mean?
- The current market value of all derivative contracts that have a negative value to the company.